Hong Zhao, Xiao-Wu Huang, Zhen Huang, Jiansong Ji, Liyun Zheng, Yinying Lu, Xin Zheng, Yong-Yi Zeng, Jia Luo, Yongchang Zhang, Jun Lu, Ping Du, Wen Zhang, Bo Chen, Shunda Du, Jian Zhou. "First-in-human phase I/II study of MRG006A, a first-in-class Glypican-3 (GPC3)–targeted antibody-drug conjugate (ADC), in patients (pts) with advanced hepatocellular carcinoma (HCC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3028